Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis: A Pilot Feasibility Treatment Study

NCT07001878 is registered in ClinicalTrials.gov with Nova Scotia Health Authority as lead sponsor.

NCT NCT07001878
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07001878 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabis Potency Effects on Brain White Matter in Early Phase Psychosis: A Pilot Feasibility Treatment Study
Lead sponsor
Nova Scotia Health Authority
Phase
Phase 4
Overall status
Recruiting
Start date
March 18, 2025
Completion date
December 1, 2026
Enrollment
24 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cannabis use, psychosis